Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Journal of Clinical Pharmacology|January 26, 2008
Effect of itraconazole on the pharmacokinetics of imidafenacin in healthy subjectsTomoya Ohno, Kazuki Nakayama, Susumu Nakade, et al.British Journal of Clinical Pharmacology|February 7, 2008
Absolute bioavailability of imidafenacin after oral administration to healthy subjectsTomoya Ohno, Susumu Nakade, Kazuki Nakayama, et al.Biological & Pharmaceutical Bulletin|November 6, 2007
Application of the correlation of in vitro dissolution behavior and in vivo plasma concentration profile (IVIVC) for soft-gel capsules--a pointless pursuit?Hidekatsu Nishimura, Chiaki Hayashi, Tetsuya Aiba, et al.Cancer Chemotherapy and Pharmacology|March 5, 2008
Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomitingSusumu Nakade, Tomoya Ohno, Junsaku Kitagawa, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 14, 2007
Ultra sensitive determination of limaprost, a prostaglandin E1 analogue, in human plasma using on-line two-dimensional reversed-phase liquid chromatography-tandem mass spectrometryJunji Komaba, Yoriko Masuda, Yoshitaka Hashimoto, et al.Biological & Pharmaceutical Bulletin|April 2, 2009
In vitro metabolism and inhibitory effects of pranlukast in human liver microsomesKazuhiro Yoneda, Ichiro Matsumoto, Fumitaka Sutoh, et al.Journal of Anesthesia|September 5, 2014
Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in gynecologic patientsTakayuki Kunisawa, Akio Yamagishi, Manabu Suno, et al.Therapeutics and Clinical Risk Management|February 6, 2015
Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in patients with peripheral arterial diseaseTakayuki Kunisawa, Akio Yamagishi, Manabu Suno, et al.Clinical and Translational Science|May 13, 2021
A phase I study of high dose camostat mesylate in healthy adults provides a rationale to repurpose the TMPRSS2 inhibitor for the treatment of COVID-19Junsaku Kitagawa, Hayato Arai, Hiroyuki Iida, et al.Respirology (Carlton, Vic.)|August 26, 2009
Impact of pharmacokinetics and pharmacogenetics on the efficacy of pranlukast in Japanese asthmaticsKoichiro Asano, Susumu Nakade, Tetsuya Shiomi, et al.Pageof 3